Atorvastatin and Erythromycin Interaction

Drug interaction information between Atorvastatin and Erythromycin.

Atorvastatin and Erythromycin have a documented minor interaction in FDA labeling.

FDA drug labeling documents a minor-severity interaction between Atorvastatin and Erythromycin. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Atorvastatin

HMG-CoA Reductase Inhibitor (Statin)

Drug B

Erythromycin

Macrolide Antibiotic

How They Interact

Erythromycin slows down the process of clearing atorvastatin from your system, leading to higher drug levels.

FDA Label Information

Examples: Erythromycin, clarithromycin, itraconazole, ketoconazole, posaconazole, and voriconazole.

Frequently Asked Questions

What SPL severity band is on file for Atorvastatin + Erythromycin?

Compiled FDA labeling labels this pair minor. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Erythromycin has 63 labeled pairs on file vs Atorvastatin's 36. In the minor band specifically: Atorvastatin has 25 (also Estradiol, Norethindrone, Ketoconazole, Rifampin); Erythromycin has 53 (also Acetaminophen/Oxycodone, Alprazolam, Bromocriptine, Buprenorphine).

What mechanism field is on file for Atorvastatin and Erythromycin?

Erythromycin slows down the process of clearing atorvastatin from your system, leading to higher drug levels.

Erythromycin carries more major-labeled pairs than Atorvastatin

SPL source-record counts only. This page's band is minor · classes on file: Atorvastatin (HMG-CoA Reductase Inhibitor (Statin)); Erythromycin (Macrolide Antibiotic).

Erythromycin has 4 major-labeled pairs vs Atorvastatin's 3. This page itself is in the minor band, not the major band.

Atorvastatin

3 major · 8 moderate · 25 minor · 36 total

Erythromycin

4 major · 6 moderate · 53 minor · 63 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.